Product Description
Follitropin alfa is a hormone identical to follicle-stimulating hormone (FSH) produced by the pituitary gland. FSH helps to develop eggs in the ovaries. (Sourced from: https://www.mayoclinic.org/drugs-supplements/follitropin-alfa-subcutaneous-route/description/drg-20063905)
Mechanisms of Action: CG Stimulant
Novel Mechanism: No
Modality: Peptide/Protein
Route of Administration: Subcutaneous
FDA Designation: None *
Approval Status: Approved
Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Canada | Chile | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | European Medicines Agency | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Japan | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Mexico | Morocco | Netherlands | New Zealand | Norway | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: Merck KGaA
Company Location: GERMANY HRB 6164 I8
Company CEO: Belen Garijo
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: Australia, China
Active Clinical Trial Count: 9
Highest Development Phases
Phase 3: Anovulation|Other|Polycystic Ovary Syndrome
Phase 1: Acute Respiratory Distress Syndrome|Healthy Volunteers
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
Recombinant-human FSH (Bemfola®) in the late follicular phase | P3 |
Active, not recruiting |
Unknown |
2019-11-16 |
|
2006-7041-83/hah | P1 |
Not yet recruiting |
Acute Respiratory Distress Syndrome |
None |
|
CTR20210004 | P1 |
Recruiting |
Healthy Volunteers |
None |
|
CTR20212627 | P1 |
Not yet recruiting |
Polycystic Ovary Syndrome |
None |